Gabriella posted on December 04, 2009 17:33
PharmiWeb VoxPop : Jonathan Peacock, Novartis - Creating Value in Pharma
Jonathan Peacock, Chief Financial and Administration Officer of Novartis, gave a keynote address entitled ‘Creating Value in Pharma – the CFO’s Perspective’ at the Financial Times Global Pharmaceutical and Biotech Conference, which took place in London on November 17th and 18th.
Value creation is a continuous challenge within the pharma and biotech industry, made even more difficult with the current climate of cost reductions, M&A deals, and a declining ROI in R&D.
Peacock discussed the future trends and changes within the pharma and biotech industry with the unique insight and awareness of a CFO.
New trends and changes highlighted by Peacock included:
-
A more targeted therapy era taking over the recent blockbuster era - the move towards more specific and differentiated therapy areas, looking at subgroups of patients
-
Growing patient influence with needs for better information and access to medicine
-
An ageing population, resulting in the need for more healthcare treatment
-
Poor health habits and sedentary lifestyles resulting in increasing of chronic diseases
-
New technological discoveries allowing the development of innovative medicines
Other significant changes in the industry discussed by Peacock included the shift in influences with payers, patients and providers taking a more important role, and more focus on understanding patient needs and delivering outcomes for patients.
We were lucky enough to get a few minutes of Mr Peacock's time during the conference.
Click below to see Jonathan Peacock, Chief Financial and Administration Officer of Novartis talking to PharmiWeb.com about the future trends in pharma.
(Jonathan Peacock joined Novartis in 2005 as Chief Financial & Administration Officer, Pharma. Jonathan is responsible for Finance, IT, Strategic Planning and Purchasing, in addition to M&A for Pharma.Jonathan also spent seven years as a partner at McKinsey and Co., where he co-led the European Corporate Finance Practice. Prior to McKinsey Jonathan was a partner at Price Waterhouse in London and New York.He has a Masters degree in Economics from the University of St Andrews and is a Member of the Institute of Chartered Accountants in England and Wales.n Peacock, Chief Financial & Administration Officer,Novartis Pharma AG)